PROGNOSIS OF
in 11 patients (8 males/3 females) who had previously undergone repair of tetralogy of Fallot. A wide spectrum of conduction system abnormalities including sinus node dysfunction (5/11), atrioventricular node dysfunction (3/11), and HisPurkinje disease (7111) were found. Confirmation that bifasicular disease cannot be reliably diagnosed from the surface electrocardiogram alone was obtained. Spontaneous and/or inducible ventricular dysrkythmias were documented in 5/11 patients. However, there was no consistent relationship between the presence or degree of residual right ventricular hypertension and the presence of ventricular dysrhythmias. We co~clude that: 1) frequent conductior~ abnormalities as well as ventricular dysrhythmias may occur in patients following repair of tetralogy of Fallot; and 2) ventricular dysrhythmias may occur in these patients even when residual right ventricular hypertension is not present. We therefore recommend that all patients should undergo postoperative hemodynamic and electrophysiologic study following intracardiac repair of tetralogy of Fallot. Sick sinus syndrome is a frequent complication following Mustard operation. Between October l 9 p and May 1985, we performed the Mustard operation on 78 patients with transposition of the great arteries. Sixty-six patients were followed long-term for up to 10 years after surgery. We reviewed patient records and Holter monitor recordings in these latter 66 patients to determine if the degree of bradycardia predicted symptoms requiring permanent pacing. A total of 8/66 patients received pacemakers. Indications for pacing included asymptomatic bradycardia during the first postoperative month, symptomatic bradycardia (seizures and syncope) late following surgery, and use of antiarrhythmic drugs other than digoxin for the control of symptomatic atrial flutter or supraventricular tachycardia. The mean minim1 heart rates documented by Holter monitor recordings did not differ significantly between the asymptomatic and symptomatic patients (p 0.15). We conclude that the degree of bradycardia is not a reliable predictor of symptoms or the need for pacing in postoperative Mustard patients during early and intermediate duration follow-up.
QUANTITATION OF LASER IRRADIATION BY-PRODUCTS
, Thoma A. R e e nment of In-vivo laser irradiation can create hazardous by-products. The purpose of the study was to evaluate the nature of the debris, and quantitate them. Segments of fresh porcine myocardium and vascular wall were irradiated in sodium phosphate buffer, with Argon laser. The amounts of tissue vaporized and accumulation of tissue debris were measured, and analyzed with Scanning Electron Microscopy (SEMI. Gasseous & thrombi by-products & temperature changes were measured in an artificial circulation using a centrifugal pump (Bio-medicus 520D). Blood was heparinized (5000 u) and circulated @ 2l/min. Continous laser irradiation of the blood was done @ 6 112 watts with 400 micron regular quartz or hot-tip fiber, for 10 minutes. Vascular walls and myocardial debris formed st a rate of 227 and 61.5 mg respectively per 1,000 mg tissue lased, showing charred fragmented tissue segments on SEM with sizes ranging up to 3 mm. Fragments of cell wall, and intracellular membranes were also identified. 23.5 and 15.5 m l of gas were formed by both fiberoptic and hot-tip irradiation respectively. Temperature elevations were between 1 and 3.9'~ in lasing chamber and 1 and ~O C in downstream chamber. 15x5 and 6x4 mm charred thrombi formed at catheter tip respectively, regardless of anticoagulant used. In conclusion: very significant amounts of gas, tissue debris and charred thrombi were formed during continuous lasing process to the extent that' modifications in laser techniques and application must be developed before laser therapy can be applied in clinical settings. Burstein. U N M School o f M e d i c i n e , UNM Hospital, Dept Ped, Albuquerque, NM W e studied patterns of head and somatic growth (height-ht, weight-wt and head circumference-OFC) in 30 infants with CHD. Infants referred in the first 3 mos of life for CHD requiring chronic medical or surgical therapy were enrolled if they had no recognizeable syndrome, intrauterine infection or chromosomal anomaly. Measurements of ht, wt, OFC and were made at 3,6,12,15, and 24 mo of age.
HEAD GROWTH IN INFANTS WITH CONGENITAL HEART DISEASE (CHD)
8 initially were cyanotic, 3 have died, and 22 have undergone surgery at a mean age of 15 mos. As a group, the infants developed normally but grew poorly, with wt (20th percentile-%-at 18 months) affected more than OFC and ht (30th % at 18 months). 11 of the 30 showed no growth failure; 2 of those 11 were cyanotic, 1 has died and 6 are postop. Of the 19 with growth failure, 10 were cyanotie, 2 have died and 16 are post-op.
Therapy made no impact on growth patterns of 12 of the 19; but 7 of the growth failure group exhibited catch-up growth (wt> ht?OFC) following surgery at a mean age of 8 months. Mean OFC increased from the 10th to the 25th % following surgery, even though OFC fell below the 5th % in 4 subjects. Catch-up head growth can accompany catch-up growth in ht and wt following successful surgery in some children with CHD; in others, normal or delayed growth patterns are unaffected by therapy.
